Edwards SAPIEN 3 TAVI Receives Expanded Approval In Europe
Go back to Edwards SAPIEN 3 TAVI Receives Expanded Approval In Europe| Edwards Lifesciences (NYSE: EW) | Delayed: 83.37 +0.74 (0.90%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $82.63 | 52 Week High | $166.87 | |||
| Open | $83.30 | 52 Week Low | $72.20 | |||
| Day High | $84.12 | P/E | 24.24 | |||
| Day Low | $81.16 | EPS | $3.44 | |||
| Volume | 3,343,850 | |||||
